Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box

Dick C Chan1, Gerald F Watts

  • 1Metabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

Insights

Familial hypercholesterolemia (FH) involves high LDL cholesterol and early heart disease. Postprandial dyslipoproteinemia may worsen this risk, warranting further investigation and potential new treatments.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is an inherited condition causing high LDL cholesterol and premature coronary heart disease (CHD).
  • Elevated LDL cholesterol alone doesn't fully explain the CHD risk variation in FH patients.
  • LDL receptor gene mutations are the primary cause of FH.

Purpose of the Study:

  • To propose a hypothetical model for the role of postprandial dyslipoproteinemia in FH.
  • To explore how LDL receptor deficiency might lead to postprandial dyslipoproteinemia.
  • To investigate factors influencing postprandial dyslipoproteinemia in FH, such as gene variants and comorbidities.

Main Methods:

  • The study proposes a hypothetical model, not experimental research.
  • It reviews existing knowledge on FH, LDL metabolism, and dyslipoproteinemia.
  • The model suggests further research is needed to validate its components.

Main Results:

  • A hypothetical model is presented linking LDL receptor deficiency to postprandial dyslipoproteinemia.
  • Overproduction and decreased catabolism of triglyceride-rich lipoproteins are implicated.
  • FH patients with specific gene variants, obesity, or insulin resistance may have increased postprandial dyslipoproteinemia.

Conclusions:

  • Postprandial dyslipoproteinemia may contribute to CHD risk in FH beyond elevated LDL cholesterol.
  • The severity of postprandial dyslipoproteinemia in FH could be influenced by genetic factors and metabolic conditions.
  • Further research is essential to validate the proposed model and assess if targeting postprandial dyslipoproteinemia reduces CHD risk in FH.

Related Concept Videos

Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...